| Literature DB >> 30797568 |
Justine Benevent1, Mélanie Araujo2, Caroline Hurault-Delarue2, Jean-Louis Montastruc3, Agnès Sommet3, Isabelle Lacroix2, Christine Damase-Michel4.
Abstract
Taking a medication is usually a challenge for a pregnant woman as the beneficial drug effect on the mother has to be considered regarding its potential adverse effects, not only for her but also for her unborn child. As medication use is common in pregnant women, by chance or necessity, it gives the opportunity to evaluate the consequences of prenatal drug exposure in real life through pharmacoepidemiological studies. This paper provides an overview of data sources, study designs and data analysis methods that can be used for pregnancy medication safety studies. In the future, the implementation of responsive international networks may be the keystones of drug evaluation in pregnancy.Entities:
Keywords: Data sources; Long-term effects; Pharmacoepidemiology; Pregnancy
Mesh:
Substances:
Year: 2019 PMID: 30797568 DOI: 10.1016/j.therap.2018.11.014
Source DB: PubMed Journal: Therapie ISSN: 0040-5957 Impact factor: 2.070